Piper Jaffray Starts Zeltiq At Overweight, Sees Upside Of $35/Share

By: via Benzinga
In a report published Monday, Piper Jaffray analyst Matt O'Brien initiated coverage of Zeltiq Aesthetics Inc (NASDAQ: ZLTQ) with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.